Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
BRL | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 635 | 684 | 814 | 1,066 | 1,051 | 1,436 | 2,668 | 2,331 | 1,879 | 2,110 | | 2,110 |
% Growth | NA | 7.7% | 19.0% | 31.0% | -1.5% | 36.7% | 85.8% | -12.6% | -19.4% | 12.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (558) | (597) | (710) | (929) | (926) | (1,185) | (2,189) | (2,143) | (1,700) | (1,849) | | (1,849) |
Gross Profit | 77 | 87 | 104 | 137 | 124 | 251 | 480 | 188 | 180 | 261 | | 261 |
% Revenue | 12.1% | 12.7% | 12.8% | 12.9% | 11.8% | 17.5% | 18.0% | 8.1% | 9.6% | 12.4% | | 12.4% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (31) | (32) | (35) | (46) | (41) | (46) | (65) | (68) | (65) | (73) | | (73) |
General and Admin | (26) | (29) | (34) | (41) | (42) | (44) | (66) | (66) | (61) | (72) | | (72) |
Other Inc / (Exp) | 2 | 2 | 3 | 20 | 0 | 74 | 67 | 49 | 1 | 68 | | 68 |
Total Operating Exp | (55) | (59) | (66) | (67) | (82) | (15) | (64) | (85) | (124) | (78) | | (78) |
| | | | | | | | | | | | |
Operating Income | 22 | 28 | 38 | 70 | 42 | 236 | 416 | 103 | 56 | 184 | | 184 |
% Revenue | 3.5% | 4.1% | 4.7% | 6.6% | 4.0% | 16.4% | 15.6% | 4.4% | 3.0% | 8.7% | | 8.7% |
| | | | | | | | | | | | |
Interest Expense | (5) | (7) | (14) | 7 | (14) | 41 | 25 | (15) | (23) | (64) | | (64) |
Pre-tax Income | 17 | 21 | 25 | 77 | 28 | 277 | 441 | 88 | 33 | 120 | | 120 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (6) | (6) | (7) | (13) | (10) | (94) | (148) | (32) | (19) | (35) | | (35) |
Net Income to Company | 11 | 15 | 17 | 64 | 18 | 182 | 293 | 56 | 13 | 85 | | 85 |
% Margin | 1.7% | 2.2% | 2.1% | 6.0% | 1.7% | 12.7% | 11.0% | 2.4% | 0.7% | 4.0% | | 4.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 11 | 15 | 17 | 64 | 18 | 182 | 293 | 56 | 13 | 85 | | 85 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 11 | 15 | 17 | 64 | 18 | 182 | 293 | 56 | 13 | 85 | | 85 |
% Margin | 1.7% | 2.2% | 2.1% | 6.0% | 1.7% | 12.7% | 11.0% | 2.4% | 0.7% | 4.0% | | 4.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.49 | 0.65 | 0.75 | 2.75 | 0.74 | 7.63 | 12.26 | 2.33 | 0.56 | 3.54 | | 3.54 |
Diluted EPS (Continuing Ops) | 0.49 | 0.65 | 0.75 | 2.75 | 0.74 | 7.63 | 12.26 | 2.33 | 0.56 | 3.54 | | 3.54 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 22.68 | 22.86 | 23.10 | 23.37 | 23.93 | 23.93 | 23.93 | 23.93 | 23.93 | 23.93 | | 23.93 |
WA Diluted Shares Out. | 22.68 | 22.86 | 23.10 | 23.37 | 23.93 | 23.93 | 23.93 | 23.93 | 23.93 | 23.93 | | 23.93 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 17 | 21 | 25 | 77 | 28 | 277 | 441 | 88 | 33 | 120 | | 120 |
Addback: Net Interest Expense | 5 | 7 | 14 | (7) | 14 | (41) | (25) | 15 | 23 | 64 | | 64 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (55) | | (55) |
Addback: Depreciation & Amortization | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 11 | 13 | 15 | | 15 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 30 | 36 | 48 | 80 | 52 | 246 | 426 | 114 | 69 | 143 | | 143 |
% Margin | 4.7% | 5.3% | 5.9% | 7.5% | 4.9% | 17.1% | 16.0% | 4.9% | 3.7% | 6.8% | | 6.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 22 | 28 | 38 | 70 | 42 | 236 | 416 | 103 | 56 | 128 | | 128 |
% Margin | 3.5% | 4.1% | 4.7% | 6.6% | 4.0% | 16.4% | 15.6% | 4.4% | 3.0% | 6.1% | | 6.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 11 | 15 | 17 | 64 | 18 | 182 | 293 | 56 | 13 | 85 | | 85 |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted Net Income | 11 | 15 | 17 | 64 | 18 | 182 | 293 | 56 | 13 | 85 | | 85 |
% Margin | 1.7% | 2.2% | 2.1% | 6.0% | 1.7% | 12.7% | 11.0% | 2.4% | 0.7% | 4.0% | | 4.0% |